Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.01% | 118.01% | 154.30% | 120.40% | 145.63% |
| Total Depreciation and Amortization | 3.17% | 6.54% | 9.09% | 77.79% | 55.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -186.05% | -226.69% | -790.04% | 194.20% | 155.03% |
| Change in Net Operating Assets | 106.12% | -273.31% | -141.94% | -139.85% | -151.86% |
| Cash from Operations | 5.48% | -26.38% | -27.48% | 30.02% | -0.57% |
| Capital Expenditure | 38.38% | -23.85% | 19.77% | -3.43% | -58.06% |
| Sale of Property, Plant, and Equipment | -42.60% | 15.46% | -15.41% | -78.47% | -74.83% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -135.37% | 90.33% | 98.33% | 264.92% | 307.32% |
| Cash from Investing | 32.48% | -23.86% | 20.59% | -23.31% | -130.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 39.40% | 62.54% | 47.48% | 7.54% | 0.48% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.13% | 1.23% | -5.88% | -71.18% | -93.27% |
| Cash from Financing | 17.62% | 38.73% | 25.08% | -19.32% | -23.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 143.49% | -19.77% | -57.92% | 135.96% | -280.32% |
